The city of Washington, District Of Columbia, currently has 18 active clinical trials seeking participants for Diabetes research studies.
Plant-based Diet for Kidney Transplant Recipients
Recruiting
The goal of this clinical trial is to evaluate cardiometabolic and inflammatory parameters in kidney transplant recipients after transitioning to a plant-based diet (PBD). The main aims of the study are as follows: * To test the feasibility of transiting renal allograft recipients who are \> 3 months post-transplant to a PBD * To study the effect of a PBD on cardiometabolic parameters in kidney transplant recipients * To assess the effect of a PBD on peripheral blood Th17/Treg ratio and systemi... Read More
Gender:
ALL
Ages:
Between 18 years and 80 years
Trial Updated:
05/15/2024
Locations: Transplant Institute, Washington, District of Columbia
Conditions: Kidney Disease, Chronic, Transplant Complication, Hypertension, Diabetes Mellitus, Metabolic Syndrome, Inflammation, Kidney Transplant Failure, Dietary Habits
Diabetes Reversal Online Program and Study (DROP Study)
Recruiting
This is an interventional study that will evaluate the feasibility, implementation, and efficacy of an online, 12-week, plant-based, nutrition education program in a community setting. Data will also be analyzed to see if participation in the program results in reductions glycated hemoglobin levels, body weight, and cholesterol levels.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
04/16/2024
Locations: Physician Committee for Responsible Medicine, Washington, District of Columbia
Conditions: Type 2 Diabetes
The Effect of a Low-fat Vegan Dietary Intervention on Intracellular Lipid, Insulin Sensitivity, and Glycemic Control in Type 2 Diabetes
Recruiting
The goal of this 16-week clinical trial is to assess the health benefits of a low-fat vegan diet on insulin sensitivity and glycemic control in type 2 diabetes. Participants will receive at no cost, study-related weekly nutrition education classes and one-on-one consultation with a registered dietitian.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
02/22/2024
Locations: Physicians Committee for Responsible Medicine, Washington, District of Columbia
Conditions: Diabetes Mellitus, Type 2, Diabetes Mellitus Type 2 in Obese
Reshaping Postpartum Follow-up
Recruiting
The aim of this study is to evaluate the impact of personalized postpartum follow-up cards on completion of postpartum health related tasks. The intervention will consist of a card given to patients at time of discharge. One side of the card will list the patient's name and a list of recommended postpartum follow-up appointments based on their diagnoses at the time of discharge. Participants will be randomized to this intervention or the control group, which will consist of standard education ro... Read More
Gender:
FEMALE
Ages:
18 years and above
Trial Updated:
09/19/2023
Locations: Washington Hospital Center, Washington, District of Columbia
Conditions: Hypertension in Pregnancy, Gestational Diabetes, Cervical Dysplasia
Group Visits for High Risk Type 1 Diabetes (T1D)
Recruiting
The investigators propose to conduct a pilot prospective cohort study to assess the impact of shared medical appointments (SMA) visits in underserved youth with poorly controlled type 1 diabetes (T1D). The trial will employ an enrollment visit, SMA visits every 3 months over a 12 month study period, followed by a 6-month observational period to assess feasibility and acceptability of SMA and the impact on glycemic control, self-management skills, and health related quality of life.
Gender:
ALL
Ages:
8 years and above
Trial Updated:
08/31/2023
Locations: Children's National Hospital, Washington, District of Columbia
Conditions: Type 1 Diabetes
Transform CV Risk in Diabetes
Recruiting
This initiative supports a real-world study of practice and physician prescribing patterns and a quality improvement initiative evaluating best practices (including clinical decision support, facilitated referral to cardiometabolic team-based care model, and general educational tools/resources) to im-prove use of guideline-directed therapeutics known to lower cardiovascular risk (CV) in patients with type 2 diabetes (T2D).
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/13/2023
Locations: Multiple sites nationwide, Washington, District of Columbia
Conditions: Type 2 Diabetes